Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
09/2008
09/09/2008US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
09/09/2008US7423149 Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders
09/09/2008US7423147 Therapy of Histamine H3 receptor mediated diseases
09/09/2008US7423058 Inhibitors of hepatitis C virus NS3 protease
09/09/2008CA2366205C Biphenyl derivatives
09/04/2008WO2008106635A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors
09/04/2008WO2008104595A1 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms
09/04/2008WO2008104582A2 Novel method for producing teta by means of eddn
09/04/2008US20080214612 for therapy of endometriosis and/or uterine leiomyoma/leiomyomata; 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine
09/04/2008US20080214571 e.g. 1-(3-Phenylsulfonyl-phenyl)piperazine; serotonin receptor modulator; anxiolytic agent, antidepressant, cognition activator; schizophrenia, obesity, Alzheimer's disease
09/04/2008US20080214570 Therapeutic Agents
09/04/2008US20080214562 Chemical Compounds
09/04/2008US20080214554 Methods for preventing or treating cardiac arrhythmia
09/04/2008US20080214543 Antiandrogen; prostate cancer; excellent oral pharmacokinetics
09/04/2008US20080214541 Such as 2-(1-naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; differentiating cells into osteoblast lineage; osteoporosis
09/04/2008CA2679489A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors
09/04/2008CA2678043A1 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms
09/03/2008EP1963296A2 Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
09/03/2008EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
09/03/2008EP1257541B1 Polypharmacophoric agents
09/03/2008CN101258138A Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands
09/03/2008CN101255152A Preparation method and use of piperazine having cytotoxic activity
09/03/2008CN101255119A Novel tetrahydro curcumin derivatives and salt
09/03/2008CN100415861C Soft compound and use thereof
09/03/2008CN100415729C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
09/03/2008CN100415728C Alkylol piperazine derivative optical isomer or its salt and its application for preparing medicament
09/02/2008US7420003 Compounds and a novel process for their preparation
09/02/2008US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
09/02/2008US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes
09/02/2008US7419974 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
09/02/2008CA2387999C Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/28/2008WO2008101914A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
08/28/2008US20080207701 Opioid receptor antagonists
08/28/2008US20080207693 Mitotic Kinesin Inhibitors
08/28/2008US20080207689 Formamide Derivatives For The Treatment of Diseases
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008US20080207633 Conjugated to polyoxyethylene glycol; analgesics; antidiabetic agents; anticancer agents; sleep disorders; antidepressants; anxiolytic agents
08/28/2008US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects
08/28/2008US20080207606 Immunology diseases; analgesics; antiarthritic agents; cardiovascular disorders; antiischemic agents; skin disorders;antiulcer agents; bone disorders; antihistamines
08/28/2008US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles
08/28/2008CA2675669A1 Novel compounds
08/27/2008EP1961738A1 New compounds with antiglutamatergic properties and uses thereof
08/27/2008EP1960395A1 Plasminogen activator inhibitor-1 inhibitors
08/27/2008EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors
08/27/2008EP1960343A2 Indene derivatives, their preparation and use as medicaments
08/27/2008EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
08/27/2008EP1200390B1 Production of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamides
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
08/27/2008CN100413854C Process for preparing trimetazidine and its medicinal salts
08/27/2008CN100413848C Acylsulfamoyl benzoic acid amides, plant protection agents containing same, and method for producing same
08/27/2008CN100413820C Nitroaromatic solubilizer for nitroxyls in aromatic solvents
08/26/2008US7417045 Antiinflammatory agents;to treat chemokine mediated diseases; Antitumor agents; autoimmune diseases
08/26/2008US7417043 3-substituted 4-(phenyl-N-alkyl)-piperazine derivatives; central nervous system disorders; dualistic dopaminergic action profile with antagonist-like effects on brain neurochemistry and mild agonist-like effects on normal behavior, induce inhibition of behavior in hyperactivity; oral bioavailability
08/26/2008US7417022 Amino acid for deliverying active materials; bioavailability
08/21/2008WO2008099286A2 Improved process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2- piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide
08/21/2008WO2008098751A1 New compounds with antiglutamatergic properties and uses thereof
08/21/2008WO2008075184A3 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
08/21/2008US20080200474 Novel flunarizine salt forms and methods of making and using the same
08/21/2008US20080200471 central nervous system disorders; mood or cognitive disorder; gastrointestinal disorders; 4-methyl-7-[(6-piperazin-1-yl-1H-indol-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazine; 1-methyl-5-[(6-piperazin-1-yl-1H-indol-1-yl)sulfonyl]-1H-indole; 6-(6-Piperazin-1-yl-indole-1-sulfonyl)-4H-benzo[1,4]oxazin-3-one
08/21/2008US20080200467 alpha keto amides and alpha hydroxy amides; N-[3-(3-Morpholin-4-yl-propoxy)-phenyl]-2-oxo-2-(4-trifluoromethyl-phenyl)-acetamide; N-Adamantan-1-yl-2-(3-benzyloxyphenyl)-2-hydroxy-acetamide; hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases
08/21/2008US20080200466 Organic Compounds For the Treatment of Inflammatory or Allergic Conditions
08/21/2008US20080200460 Chemical Compounds
08/21/2008US20080200459 Tetrahydroquinoline cannabinoid receptor modulators
08/21/2008US20080200456 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine
08/20/2008EP1957473A2 Process for preparing substituted aryl cycloalkanol derivatives
08/20/2008EP1957472A1 Method for producing ionic liquids
08/20/2008EP1957470A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
08/20/2008EP1957449A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1285909B1 Process for the production of nitrogen compounds
08/20/2008EP1249233B1 Npyy5 antagonists
08/20/2008CN101248069A Androgen receptor modulators and method of treating disease using the same
08/20/2008CN101248053A N-oxides as prodrugs of piperazine and piperidine derivatives
08/20/2008CN101245039A Process for producing cis-4-(2-bromine vinyl)benzene sulfonamide(I)
08/19/2008US7414076 Methods and compositions for treating amyloid-related diseases
08/19/2008US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
08/19/2008US7414053 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease
08/19/2008US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides
08/19/2008US7414041 Reducing tetracycline resistance in living cells
08/14/2008US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia
08/14/2008US20080194564 the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and processes for the preparation of these
08/14/2008US20080194551 Acetylene Derivatives
08/14/2008US20080194536 Cyanoarylamines
08/14/2008US20080193383 administering delta receptor angonists such as diarylmethyl piperazine and diarylmethyl piperidine compounds; side effect reduction of anesthetics, barbiturates and analgesics
08/13/2008EP1954678A1 Novel nk1 and nk2 antagonists
08/13/2008EP1824837B1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds
08/13/2008EP1581467A4 Ligands for metals and improved metal-catalyzed processes based thereon
08/13/2008EP1572632B1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
08/13/2008EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
08/13/2008EP0934924B1 Novel diamide compounds and drugs containing the same
08/13/2008CN101243047A Phenoxy acetic acids as PPAR delta activators
08/13/2008CN101239957A Method for synthesizing N-methylpiperazine
08/13/2008CN101239928A Propanoic derivatives for treating lipid metabolism disorder
08/13/2008CN100409939C Catalyst for synthesizing morphine through diethylene glycol ammoniation, and preparation method
08/12/2008US7411092 Quaternary ammonium salts
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7411004 Sulphones which modulate the action of gamma secretase
08/12/2008US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/12/2008US7410971 1,2-di(cyclic)substituted benzene compounds
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 341